Board meeting on 30 October 2026 to consider Unaudited Q2/H1 FY27 results; trading window closed
The Board of Directors is scheduled to meet on Friday, 30 October 2026.
By ScoutQuest · · 1 min read
- Board Meeting Date
- Friday, 30 October 2026
- Agenda
- considering and approving the Unaudited Standalone and Consolidated Financial Results for the quarter and half year ended 30 September 2026
- Trading Window Closure
- closed from Thursday, 1 October 2026 until 48 hours after results, i.e. up to and including Sunday, 1 November 2026
Results date announced
The company has informed the exchanges that a meeting of its Board of Directors is scheduled to be held on Friday, 30 October 2026.
At that meeting, the Board will consider and approve the Unaudited Standalone and Consolidated Financial Results of the company for the quarter and half year ended 30 September 2026.
For a retail investor, this is the date on which the September quarter numbers are slated to come up before the Board for consideration and approval.
Trading window closed
- The Trading Window for dealing in the securities of the company has been closed with effect from Thursday, 1 October 2026.
- It shall remain closed until 48 hours after the declaration of the financial results, that is, up to and including Sunday, 1 November 2026.
- The company says this follows its earlier communication dated 25 September 2026.
What is a trading window?
The trading window is the period during which insiders and designated persons connected with a company are permitted to buy or sell its shares. When the window is closed, such persons cannot deal in the securities. This is a standard practice to prevent insiders from trading at a time when they may be in possession of price-sensitive information about the company, such as results that are yet to be made public.
What this update tells you
- A date is now fixed — 30 October 2026 — for the Board meeting at which the September quarter and half-year results will be considered and approved.
- The trading window stays shut from 1 October 2026 until 48 hours after those results are declared, which the update puts at up to and including 1 November 2026.
The intimation is signed by Anoop Deshpande, Company Secretary and Compliance Officer.
Also from Sun Pharmaceutical Industries
Sun Pharma to present long-term UNLOXCYT data in advanced CSCC at ESMO 2026
23 Oct 2026
UNLOXCYT elevated to NCCN Category 2A option for locally advanced CSCC
20 Oct 2026
Sun Pharma to announce Q2 results on 30 October 2026; earnings call at 6:30 pm IST
15 Oct 2026
More numbers
- Period after declaration of results until which trading window stays closed48 hours
Nothing here is a view, opinion or recommendation of ScoutQuest, its parent, directors or employees. ScoutQuest is a technology company: this page was assembled automatically from public sources using artificial intelligence, and may contain errors or omissions. Confirm everything against the original source before you act on it. Any use of this page is at your own risk, and neither ScoutQuest nor its parent, directors or employees accepts liability for it.